Document is current
Any future updates will be listed below
-
Authors
,
Nishimoto, Yuji
Yamashita, Yugo
Morimoto, Takeshi
Saga, Syunsuke
Amano, Hidewo
Takase, Toru
Hiramori, Seiichi
Kim, Kitae
Oi, Maki
Akao, Masaharu
Kobayashi, Yohei
Toyofuku, Mamoru
Izumi, Toshiaki
Tada, Tomohisa
Chen, Po-Min
Murata, Koichiro
Tsuyuki, Yoshiaki
Sasa, Tomoki
Sakamoto, Jiro
Kinoshita, Minako
Togi, Kiyonori
Mabuchi, Hiroshi
Takabayashi, Kensuke
Yoshikawa, Yusuke
Shiomi, Hiroki
Kato, Takao
Makiyama, Takeru
Ono, Koh
Sato, Yukihito
Kimura, Takeshi
-
Funding
Funding for this research was provided by:
Research Institute for Production Development
Mitsubishi Tanabe Pharma Corporation
- License Information
-
More Information
Article History
First Online: 5 July 2019
Compliance with ethical standards
:
: Dr. Yugo Yamashita received lecture fees from Daiichi-Sankyo, Bristol-Myers Squibb, and Bayer Healthcare. Dr. Takeshi Morimoto received lecture fees from Mitsubishi Tanabe Pharma and Pfizer Japan, and consultant fees from Asahi Kasei, Bristol-Myers Squibb, and Boston Scientific. Dr. Masaharu Akao received lecture fees from Pfizer, Bristol-Myers Squibb, Boehringer Ingelheim, Bayer Healthcare, and Daiichi-Sankyo. Dr. Takeshi Kimura received a research grant from Daiichi-Sankyo. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of retrospective study formal consent is not required.
